Live Breaking News & Updates on Mikyoung Hahn

Stay updated with breaking news from Mikyoung hahn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Blue Note Therapeutics and Bixink Enter Licensing Agreement

SAN FRANCISCO, May 09, 2022 (GLOBE NEWSWIRE) Blue Note Therapeutics and Bixink Therapeutics, a bio-subsidiary of KPS, today announced that the. ....

South Korea , South Korean , Geoffrey Eich , Mikyoung Hahn , Kim King , Drug Administration , Bixink Therapeutics Co , Note Therapeutics , Bixink Therapeutics , Blue Note , Blue Note Therapeutics , Breakthrough Device Designation , Breakthrough Device , South Korean Bio Company , Digital Therapeutics , Mental Health ,

Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription

SAN FRANCISCO - May 9, 2022 - (Newswire.com) Blue Note Therapeutics and Bixink Therapeutics, a bio-subsidiary of KPS, today announced that the companies have entered into an exclusive lic. ....

South Korea , South Korean , Geoffrey Eich , Mikyoung Hahn , Kim King , Drug Administration , Bixink Therapeutics Co , Note Therapeutics , Bixink Therapeutics , Blue Note , Blue Note Therapeutics , Breakthrough Device Designation , Breakthrough Device , South Korean Bio Company , Release Service , Bixink Enter Licensing Agreement , Prescription Digital Therapeutics , Mental Well Being ,